Completed NA INTERVENTIONAL 1-arm NCT00004138

Positron Emission Tomography for Detecting Non-small Cell Lung Cancer

The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma

Sponsor: Alliance for Clinical Trials in Oncology

Conditions Lung Cancer

Interventions fludeoxyglucose F 18 positron emission tomography radionuclide imaging

Updated 6 times since 2017 Last updated: Jul 12, 2016 Started: Sep 30, 1999 Primary completion: Dec 31, 2002 Completion: Dec 31, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Lung Cancer, this trial is completed. The trial is conducted by Alliance for Clinical Trials in Oncology and has accumulated 6 data snapshots since 1999. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Sep 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Data source: Alliance for Clinical Trials in Oncology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Baltimore, United States , Boston, United States , Charleston, United States , Chicago, United States , Clearwater, United States , Durham, United States , Greensburg, United States , Indianapolis, United States , Iowa City, United States , Lakeland, United States and 10 more locations